Finance

Lists
Q3 2026 earnings • released • EPS beat +३९.८६% • Revenue miss -०.१२%
See results
PHAT:NASDAQ
Phathom Pharmaceuticals Inc
US$ ५.७४
-७.७२%
(-०.४८) 1D
US$ ५.८५
+१.९२% (+०.११)
After hours
Closed: अक्टोबर ३०, १५:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAT...
Open
US$ ६.३२
High
US$ ६.३२
Low
US$ ५.५९
Mkt. cap
४६.६६ करोड
Avg. vol.
१५.६८ लाख
Volume
१६.२१ लाख
52-wk high
US$ १८.३१
52-wk low
US$ ५.०२
EPS
-US$ १.२७
Beta
०.५०
Shares outstanding
८.०९ करोड
No. of employees
३७१
Open
US$ ६.३२
High
US$ ६.३२
Low
US$ ५.५९
Mkt. cap
४६.६६ करोड
Avg. vol.
१५.६८ लाख
Volume
१६.२१ लाख
52-wk high
US$ १८.३१
52-wk low
US$ ५.०२
EPS
-US$ १.२७
Beta
०.५०
Shares outstanding
८.०९ करोड
No. of employees
३७१
News stories
From web sources and news partners
About Phathom Pharmaceuticals Inc
CEO-
Employees३७१
Founded२०१८
HeadquartersFlorham Park, न्यु जर्सी, संयुक्त राज्य अमेरिका
Sector-
Websitephathompharma.com
Analyst ratings
Based on 6 analysts giving stock ratings to PHAT in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PHAT in the last 3 months.
Highest
Current US$ ५.७४
US$ २६.०० (+३५२.९६%)
Average
US$ १७.४० (+२०३.१४%)
Lowest
US$ १०.०० (+७४.२२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yatin Suneja
Guggenheim
Buy
Reiterated
US$ २२.००
+२८३.३%
10/29/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
US$ २६.००
+३५३%
10/30/2026
Jenna Davidner
Barclays
Buy
Maintained
US$ १४.००
+१४३.९%
10/30/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
-
-
10/23/2026
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
US$ १५.००
+१६१.३%
10/21/2026
Daniel Clark
Leerink Partners
Hold
Initiated
US$ १०.००
+७४.२%
09/09/2026
Martin Auster
Raymond James
Buy
Maintained
US$ २१.००
+२६५.९%
07/31/2026
Joseph Stringer
Needham
Buy
Maintained
US$ २२.००
+२८३.३%
07/30/2026
Paul Choi
Goldman Sachs
Hold
Maintained
-
-
04/30/2026
Last report
२०२६ अक्टोबर २९
Fiscal period
Q3 2026
US$ ०.०४ / US$ ०.०३
+३९.८६%beat
Revenue / Est. (USD)
८.४७ करोड / ८.४८ करोड
-०.१२%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
५.७६ करोड
५.८३ करोड
७.४३ करोड
८.४७ करोड
Cost of goods sold
७६.४८ लाख
१.२० करोड
१.५१ करोड
-
Cost of revenue
७६.४८ लाख
१.२० करोड
१.५१ करोड
-
Research and development expenses
७४.९३ लाख
७७.७१ लाख
७८.१३ लाख
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४.८४ करोड
५.४० करोड
५.५३ करोड
-
Operating expense
५.५९ करोड
६.१८ करोड
६.३१ करोड
-
Total operating expenses
६.३५ करोड
७.३८ करोड
७.८२ करोड
-
Operating income
-५९.२८ लाख
-१.५५ करोड
-३९.६५ लाख
-
Other non operating income
-५.०० हजार
-८.३१ लाख
-२४.०० हजार
-
EBT including unusual items
-२.११ करोड
-३.०४ करोड
-१.७६ करोड
-
EBT excluding unusual items
-२.११ करोड
-३.०४ करोड
-१.७६ करोड
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.११ करोड
-३.०४ करोड
-१.७६ करोड
-
Net profit margin
-३६.७३%
-५२.०९%
-२३.६७%
-
Earnings per share
-०.०८
-०.१८
-
०.०४
Interest and investment income
१२.०४ लाख
१७.३६ लाख
१५.१० लाख
-
Interest expense
-१.६४ करोड
-१.५८ करोड
-१.५१ करोड
-
Net interest expenses
-१.५२ करोड
-१.४१ करोड
-१.३६ करोड
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-५८.०० लाख
-१.५४ करोड
-३८.५१ लाख
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू